Does Critical Illness Change Levofloxacin Pharmacokinetics?

Eitemau Tebyg

• We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
  gan: Cotta, Menino Osbert, et al.
  Cyhoeddwyd: (2016)
• Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
  gan: Pea, Federico, et al.
  Cyhoeddwyd: (2012)
• A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed Meninges
  gan: Kumta, Nilesh, et al.
  Cyhoeddwyd: (2020)
• Pharmacokinetics of Levofloxacin and Ciprofloxacin during Continuous Renal Replacement Therapy in Critically Ill Patients
  gan: Malone, Rebecca S., et al.
  Cyhoeddwyd: (2001)
• Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function
  gan: Cojutti, Pier Giorgio, et al.
  Cyhoeddwyd: (2017)